Goldman Sachs upgraded Bruker (BRKR) to Neutral from Sell with an unchanged price target of $60. The firm believes Bruker’s market position has improved since its initiation with a Sell rating given the company’s focused investment in high growth areas, insulating it from slower overall market growth. Despite Bruker’s improved exposure, the shares are trading at the highest discount to peers in over 10 years, the analyst tells investors in a research note.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BRKR:
- Dragonfly Energy, Bruker partner to accelerate battery tech development
- Bruker price target lowered to $70 from $72 at TD Cowen
- Bruker price target lowered to $75 from $80 at Citi
- Bruker price target lowered to $75 from $78 at Wells Fargo
- Bruker price target lowered to $69 from $75 at Barclays
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
